EIPM Director Olivier Elemento, Ph.D., Wins NIH Director’s Pioneer Award
October 6, 2026
Dr. Olivier Elemento, the director of the Englander Institute for Precision Medicine at Weill Cornell Medicine, has been awarded an NIH Director's Pioneer Award to build an artificial intelligence (AI) tool to accelerate cancer research, starting with lung cancer.
October 2026 EIPM Director's Memo
October 5, 2026
October 2026 EIPM Director's Memo
Dear Friends & Members of the Englander Institute,
Neck lymph node removal linked to increased risk of cognitive decline
October 1, 2026
Surgery to remove lymph nodes in the neck may interfere with cerebrospinal fluid (CSF) drainage from the brain, contributing to cognitive impairment, according to new multicenter research led by Weill Cornell Medicine scientists.
Neck Lymph Node Removal Linked to Increased Risk of Cognitive Decline
September 30, 2026
Surgery to remove lymph nodes in the neck may interfere with cerebrospinal fluid (CSF) drainage from the brain, contributing to cognitive impairment, according to new multicenter research led by Weill Cornell Medicine scientists.
Meet 2026 Summer Intern Salah!
September 23, 2026
We hope you enjoy learning about our 2026 EIPM summer intern Salah, who worked under EIPM Member Alexandros Sigaras MS, Assistant Professor of Research in Physiology and Biophysics, in our AI-XR Lab! Here he explains how his summer project developed, the technical skills he learned, challenges he overcame, fun he had, and how his confidence grew over time!
Applications for our summer 2027 internship will open in a few months: https://eipm.weill.cornell.edu/education/students
Why Read a Research Paper When You Can Turn It Into an AI Agent?
September 23, 2026
Why Read a Research Paper When You Can Turn It Into an AI Agent?
Smart-Start Therapy for Canine B-Cell Lymphoma
September 16, 2026
Lymphoma is one of the most common cancers we see in dogs. The current standard treatment — a combination chemotherapy protocol called CHOP — has been used for decades and can put most dogs into remission. Unfortunately, the cancer usually comes back within 6 to 12 months, and once it returns, it becomes much harder to treat.
We also know that CHOP has real drawbacks for families and their dogs: It's a big commitment. Treatment represents a significant financial investment and requires frequent visits to the veterinary hospital over several months.
A Conversation with Eleni Andreopoulou, M.D.
September 2, 2026
Q: What first drew you to medicine, and later to breast oncology?
Dr. Andreopoulou:
I was drawn to medicine from an early age by both intellectual curiosity and a desire to care for others. I grew up in a family that deeply valued education and service, and those values, combined with my love of biology, chemistry, and pharmacology, naturally led me toward medicine.
September 2026 EIPM Director's Memo
September 1, 2026
Dear Friends & Members of the Englander Institute,
Model Helps Scientists Build Better Protein-Degrading Therapies
August 31, 2026
A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer. The studywas published July 13 in Nature Communications.